- $857.30m
- $1.02bn
- $863.50m
- 45
- 76
- 43
- 54
Annual cashflow statement for OPKO Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -315 | 30.6 | -30.1 | -328 | -189 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 113 | 5.5 | 0.087 | 156 | 33.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -68.8 | -97.6 | -20.5 | 42.7 | 21.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -173 | 39.5 | 38.3 | -95.2 | -28.2 |
| Capital Expenditures | -12.7 | -33.7 | -32.2 | -24.6 | -16.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.529 | 15.4 | 68.1 | 116 | -1.92 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -13.3 | -18.3 | 35.9 | 91 | -18.2 |
| Financing Cash Flow Items | -7.76 | 0 | -0.188 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 175 | -35.1 | -10.4 | 23 | -11.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -11 | -13.2 | 62.5 | 18.5 | -57.3 |